1. 5 Clinical Evaluation of the Abuse Potential of Buprenorphine/Samidorphan Combination. (12th March 2019) Authors: Cutler, Andrew J.; Mathew, Sanjay J.; DeBakey, Michael E.; Setnik, Beatrice; Nangia, Narinder; Stanford, Arielle D.; Pathak, Sanjeev Journal: CNS spectrums Issue: Volume 24:Number 1(2019:Feb) Page Start: 176 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 50 Adjunctive Buprenorphine/Samidorphan Combination in Patients with Major Depressive Disorder: Phase 3 Long-term Extension Study Results. (12th March 2019) Authors: Thase, Michael; Stanford, Arielle D.; Memisoglu, Asli; Martin, William; Claxton, Amy; Bodnik, J. Alexander; Trivedi, Madhukar H.; Fava, Maurizio; Pathak, Sanjeev Journal: CNS spectrums Issue: Volume 24:Number 1(2019:Feb) Page Start: 203 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Abuse Potential of Buprenorphine/Samidorphan Combination Compared to Buprenorphine and Placebo: A Phase 1 Randomized Controlled Trial. (13th August 2018) Authors: Pathak, Sanjeev; Vince, Bradley; Kelsh, Debra; Shram, Megan J.; Setnik, Beatrice; Lu, Hong; Nangia, Narinder; Stanford, Arielle D.; Ehrich, Elliot Journal: Journal of clinical pharmacology Issue: Volume 59:Number 2(2019) Page Start: 206 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Abuse Potential of Samidorphan: A Phase I, Oxycodone‐, Pentazocine‐, Naltrexone‐, and Placebo‐Controlled Study. (26th November 2018) Authors: Pathak, Sanjeev; Vince, Bradley; Kelsh, Debra; Setnik, Beatrice; Nangia, Narinder; DiPetrillo, Lauren; Puhl, Matthew D.; Sun, Lei; Stanford, Arielle D.; Ehrich, Elliot Journal: Journal of clinical pharmacology Issue: Volume 59:Number 2(2019) Page Start: 218 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Cataractogenic potential of quetiapine versus risperidone in the long-term treatment of patients with schizophrenia or schizoaffective disorder: A randomized, open-label, ophthalmologist-masked, flexible-dose, non-inferiority trial. (January 2015) Authors: Laties, Alan M; Flach, Allan J; Baldycheva, Irina; Rak, Ihor; Earley, Willie; Pathak, Sanjeev Journal: Journal of psychopharmacology Issue: Volume 29:Number 1(2015:Jan.) Page Start: 69 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Efficacy and safety of pimavanserin in patients with Alzheimer's dementia psychosis in the HARMONY phase 3, randomized discontinuation study: a post hoc subgroup analysis. (20th December 2022) Authors: Cummings, Jeffrey; Devanand, Davangere P; Ballard, Clive G; Tariot, Pierre N.; Hendrix, Suzanne B.; Dickson, Samuel P.; Li, Caiyan; Abler, Victor; Pathak, Sanjeev; Stankovic, Srdjan Journal: Alzheimer's & dementia Issue: Volume 18(2022)Supplement 10 Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗